Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy
about
PSK, a novel STE20-like kinase derived from prostatic carcinoma that activates the c-Jun N-terminal kinase mitogen-activated protein kinase pathway and regulates actin cytoskeletal organizationStructural basis by which alternative splicing confers specificity in fibroblast growth factor receptorsFas-activated serine/threonine phosphoprotein (FAST) is a regulator of alternative splicingReceptor specificity of the fibroblast growth factor familyFibroblast growth factorsIdentification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervixEnhanced signaling and morphological transformation by a membrane-localized derivative of the fibroblast growth factor receptor 3 kinase domainFibroblast growth factor 8 is expressed at higher levels in lactating human breast and in breast cancerReceptor specificity of the fibroblast growth factor family. The complete mammalian FGF familyCharacterization of sequences and mechanisms through which ISE/ISS-3 regulates FGFR2 splicingExploring mechanisms of FGF signalling through the lens of structural biologyBeyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesisPromatrilysin expression is induced by fibroblast growth factors in the prostatic carcinoma cell line LNCaP but not in normal primary prostate epithelial cellsP63 alpha mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndromeHeparan sulfate fibroblast growth factor receptor complex: structure-function relationshipsReceptors for fibroblast growth factorsAlternative pre-mRNA splicing regulation in cancer: pathways and programs unhingedEndocrine treatment in prostate cancerThe nonsense-mediated decay pathway and mutually exclusive expression of alternatively spliced FGFR2IIIb and -IIIc mRNAsAlternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cellsProx1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesisExpression of the FGFR1 gene in human breast-carcinoma cellsAn intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding proteinFox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choiceNovel phosphotyrosine targets of FGFR2IIIb signaling.Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction.Isolation and serum-free culture of epithelial cells derived from epithelial rests of Malassez in human periodontal ligament.Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancerInvolvement of heparin affin regulatory peptide in human prostate cancer.Alternative splicing of fibroblast growth factor receptors in human prostate cancer.Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.Specific heparan sulfate structures modulate FGF10-mediated submandibular gland epithelial morphogenesis and differentiation.Splicing reporter mice revealed the evolutionally conserved switching mechanism of tissue-specific alternative exon selection.Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth.Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration.Dysregulated expression of growth factors and their receptors in the development of prostate cancer.Genetic and epigenetic mechanisms down-regulate FGF receptor 2 to induce melanoma-associated antigen A in breast cancer.Endothelium-derived factors as paracrine mediators of prostate cancer progression.Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models.Cellular migration and invasion uncoupled: increased migration is not an inexorable consequence of epithelial-to-mesenchymal transition
P2860
Q22011202-C53042EE-5A1E-452C-B3EE-F6D122216CF6Q24294933-85E45785-F418-4507-A874-2FDCC0DE68F1Q24314362-5358F5C0-AFEF-4F71-B925-5EBC2054823DQ24320178-06EBB068-8A37-4728-9DE8-5810DF42DD39Q24542507-EEC4533E-8277-445F-92F0-831DC19745B7Q24643437-2663F79C-8F27-4E9D-A45B-BE57526C435EQ24644538-A6A2971B-33A1-4C41-9095-25553F81869CQ24648429-29AB9FAD-FFE1-4915-A728-E8E227C90A92Q24676527-9DA483FB-8E47-42E3-8C5D-04EEDBE73BA9Q25255848-5FA57AFF-4845-48F8-A497-0216D48BFEA7Q27015054-9DFD23DD-9827-416B-8BDF-AAFEBA407E36Q27026936-D592C9E0-9C6A-42C7-883F-61A772C1B3B2Q28146127-BAD61E10-27D5-4133-8706-968FB14BFDD1Q28190562-2476BB34-9488-4D92-AD56-73DF5C2DB176Q28243095-EAC48406-7910-45A1-BD6A-D08C57EFCB60Q28285082-BD14D3A9-44C9-49F4-8DF4-B48970D98B44Q28297381-DEB50B3B-08A6-4AB5-B143-C38639F6D39CQ28378298-1F6F4BB9-3C55-4B36-BA80-6DCA34037129Q28575026-45E16B50-9571-4068-BBFD-0E539781A03FQ28582736-DDBAFE0B-EE07-4B7C-BD76-7B39982A49E3Q28587821-F3A27960-2587-4584-AFBF-859D2B075C98Q28609135-7C2148D3-A4B6-4AE8-B74E-326E4D51C446Q28609617-B897A694-759C-478B-A7F5-B5EE0372D9C0Q28768535-8E23CCFC-79C7-413C-BC61-CA57F8D13F26Q30376698-0516D3E5-1179-434E-95D2-460879B90B1FQ30439922-7405FE76-DAB9-49C2-BF2F-21B81870A9EAQ30647102-1C186AD5-E261-42D5-B26A-398450A60F35Q30764223-FA040981-AD60-466D-A51A-B9B12C612A0AQ31909575-355F3915-DA53-4E01-B582-31E7216AFBDFQ31912970-DC2E0361-B294-4670-BCB4-4964F2A81564Q33289739-F3C12E0E-A337-4956-9B76-A4710C34DDA8Q33317125-16BE75DD-BB7B-4174-BB41-B2742F334A5BQ33598477-0385B39E-8091-43E9-9474-2399F858F05DQ33703786-C2CE955B-E813-4CE6-BBA5-5EF20115C851Q33783047-DE992622-7BFF-4747-B828-95A3BF490B9BQ33807246-850D4D5A-623C-45A2-A3BB-37C911CF5E6DQ33816374-EA6F7891-5903-4BE5-9A0A-F1352F664A1AQ33947250-1C46D3B0-35BB-429F-9C04-9A5A521EC5E0Q33985578-CB98F566-E96B-4E07-AF2B-F7C6F23CDEEEQ34056621-01413B95-7485-4501-979C-5503E17904DF
P2860
Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Exon switching and activation ...... al independence and malignancy
@ast
Exon switching and activation ...... al independence and malignancy
@en
Exon switching and activation ...... al independence and malignancy
@nl
type
label
Exon switching and activation ...... al independence and malignancy
@ast
Exon switching and activation ...... al independence and malignancy
@en
Exon switching and activation ...... al independence and malignancy
@nl
prefLabel
Exon switching and activation ...... al independence and malignancy
@ast
Exon switching and activation ...... al independence and malignancy
@en
Exon switching and activation ...... al independence and malignancy
@nl
P2093
P2860
P3181
P356
P1476
Exon switching and activation ...... al independence and malignancy
@en
P2093
S Nikolaropolous
W L McKeehan
Y Fukabori
P2860
P304
P3181
P356
10.1128/MCB.13.8.4513
P407
P577
1993-08-01T00:00:00Z